BEGIN ARTICLE PREVIEW:
Prior to the COVID-19 outbreak, the medical community had pinned high hopes on efforts to tackle the prevalence of cervical cancer, which remains among the deadliest types of malignant growth for women in Indonesia despite it being the most preventable. However, the pandemic has managed to disrupt mass screening and vaccination programs.
A four-year ongoing study of cervical cancer, carried out by Gadjah Mada University’s Center for Reproductive Health and the University of Melbourne’s Nossal Institute for Global Health, found that the number of patients seeking treatment in the capital Jakarta has declined.
The researchers started conducting interviews with dozens of workers from community-based organizations, clinics and hospitals in March, when the outbreak first erupted in the country, to find out why. They discovered that some medical services were adjusted as a re…
Log in with your social account
END ARTICLE PREVIEW